Literature DB >> 9459144

Drug-induced death of leukaemic cells after G2/M arrest: higher order DNA fragmentation as an indicator of mechanism.

R J Sleiman1, D R Catchpoole, B W Stewart.   

Abstract

Many reports have documented apoptotic death in different cell types within hours of exposure to cytotoxic drugs; lower drug concentrations may cause cell cycle arrest at G2/M and subsequent death, which has been distinguished from 'classic' apoptosis. We have analysed etoposide-induced cell death in two lymphoblastoid T-cell lines, CCRF-CEM and MOLT-4, specifically in relation to DNA cleavage as indicated by pulse-field gel and conventional electrophoresis. High (5 microM) concentration etoposide causes 50-kb cleavage of DNA that occurs at the same time as apoptotic morphology and internucleosomal cleavage. At lower concentrations (0.5-0.05 microM), sequential change may be discerned with altered gene expression being similar to that at high dose, but preceding cell cycle arrest and 50-kb cleavage. These last changes, in turn, clearly precede internucleosomal fragmentation of DNA, vital dye staining and morphological evidence cell death. The pattern of higher order fragmentation constitutes a sensitive indicator of commitment to cell death in these cells. Morphological evidence of cell death is associated with internucleosomal fragmentation in one of the lines, but the pattern of 50-kb DNA cleavage provides the clearest evidence of commonality in death processes occurring at low and high drug concentration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459144      PMCID: PMC2151273          DOI: 10.1038/bjc.1998.7

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  67 in total

Review 1.  The molecular biology of apoptosis.

Authors:  D L Vaux; A Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

2.  The role of apoptosis (programmed cell death) in haemopoiesis and the immune system.

Authors:  P D Allen; S A Bustin; A C Newland
Journal:  Blood Rev       Date:  1993-03       Impact factor: 8.250

3.  Apoptosis of L929 cells by etoposide: a quantitative and kinetic approach.

Authors:  G Bonelli; M C Sacchi; G Barbiero; F Duranti; G Goglio; L Verdun di Cantogno; J S Amenta; M Piacentini; C Tacchetti; F M Baccino
Journal:  Exp Cell Res       Date:  1996-11-01       Impact factor: 3.905

4.  Cellular events in Fas/APO-1-mediated apoptosis in JURKAT T lymphocytes.

Authors:  M Weis; J Schlegel; G E Kass; T H Holmström; I Peters; J Eriksson; S Orrenius; S C Chow
Journal:  Exp Cell Res       Date:  1995-08       Impact factor: 3.905

5.  Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.

Authors:  D R Catchpoole; B W Stewart
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

6.  p53 status and the efficacy of cancer therapy in vivo.

Authors:  S W Lowe; S Bodis; A McClatchey; L Remington; H E Ruley; D E Fisher; D E Housman; T Jacks
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

Review 7.  Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators.

Authors:  B W Stewart
Journal:  J Natl Cancer Inst       Date:  1994-09-07       Impact factor: 13.506

8.  Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).

Authors:  S Grant; A J Freemerman; M J Birrer; H A Martin; A J Turner; E Szabo; J Chelliah; W D Jarvis
Journal:  Cell Growth Differ       Date:  1996-05

9.  Periodicity of DNA folding in higher order chromatin structures.

Authors:  J Filipski; J Leblanc; T Youdale; M Sikorska; P R Walker
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  The role of apoptosis in cell killing by cisplatin: a flow cytometric study.

Authors:  M G Ormerod; R M Orr; J H Peacock
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

View more
  5 in total

1.  Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells.

Authors:  Zchong-Zcho Wu; Ching-Ming Chien; Sheng-Huei Yang; Yi-Hsiung Lin; Xiu-Wei Hu; Yu-Jhang Lu; Ming-Jung Wu; Shinne-Ren Lin
Journal:  Mol Cell Biochem       Date:  2006-05-30       Impact factor: 3.396

2.  Flexible low-intensity combination chemotherapy for elderly patients with acute myeloid leukaemia: a multicentre, phase II study.

Authors:  Arumugam Manoharan; John Reynolds; Jane Matthews; Heather Baxter; Juliana Di Iulio; Michael Leahy; Surender Juneja
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

3.  Flexible low-intensity combination chemotherapy for elderly patients with acute myeloid leukemia.

Authors:  Arumugam Manoharan; Annette Trickett; Yiu Lam Kwan; Timothy Brighton
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

4.  Rhizoctonia bataticola lectin (RBL) induces caspase-8-mediated apoptosis in human T-cell leukemia cell lines but not in normal CD3 and CD34 positive cells.

Authors:  Radha Pujari; Sachin M Eligar; Natesh Kumar; Srikanth Barkeer; Vishwanath Reddy; Bale M Swamy; Shashikala R Inamdar; Padma Shastry
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

5.  Nontoxic concentration of DNA-PK inhibitor NU7441 radio-sensitizes lung tumor cells with little effect on double strand break repair.

Authors:  Shigeaki Sunada; Hideki Kanai; Younghyun Lee; Takeshi Yasuda; Hirokazu Hirakawa; Cuihua Liu; Akira Fujimori; Mitsuru Uesaka; Ryuichi Okayasu
Journal:  Cancer Sci       Date:  2016-09-01       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.